Suivre
rita murri
Titre
Citée par
Citée par
Année
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (5), 445-449, 2001
6752001
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature
A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S123-S127, 2002
6652002
Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons
A Ammassari, A Antinori, MS Aloisi, MP Trotta, R Murri, L Bartoli, ...
Psychosomatics 45 (5), 394-402, 2004
3842004
Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy
F Starace, A Ammassari, MP Trotta, R Murri, P De Longis, C Izzo, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S136-S139, 2002
3642002
Post-COVID-19 global health strategies: the need for an interdisciplinary approach
Aging clinical and experimental research 32 (8), 1613-1620, 2020
3172020
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ...
Aids 16 (3), 369-379, 2002
3092002
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays …
A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ...
Neurology 48 (3), 687-694, 1997
2871997
Patient-reported nonadherence to HAART is related to protease inhibitor levels
R Murri, A Ammassari, K Gallicano, A De Luca, A Cingolani, D Jacobson, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (2), 123-128, 2000
2092000
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian …
A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ...
Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020
1902020
Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS …
A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ...
Journal of clinical oncology 17 (2), 554-554, 1999
1871999
Determinants of health-related quality of life in HIV-infected patients
R Murri, M Fantoni, C Del Borgo, R Visona, A Barracco, A Zambelli, ...
AIDS care 15 (4), 581-590, 2003
1752003
Attitudes towards anti-SARS-CoV2 vaccination among healthcare workers: results from a national survey in Italy
F Di Gennaro, R Murri, FV Segala, L Cerruti, A Abdulle, A Saracino, ...
Viruses 13 (3), 371, 2021
1722021
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy
A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ...
Neurology 55 (8), 1194-1200, 2000
1592000
Neurocognitive performance and quality of life in patients with HIV infection
V Tozzi, P Balestra, S Galgani, R Murri, R Bellagamba, P Narciso, ...
AIDS research and human retroviruses 19 (8), 643-652, 2003
1492003
The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy
A De Luca, ML Giancola, A Ammassari, S Grisetti, MG Paglia, M Gentile, ...
The Journal of infectious diseases 182 (4), 1077-1083, 2000
1392000
Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART
V Tozzi, P Balestra, R Murri, S Galgani, R Bellagamba, P Narciso, ...
International journal of STD & AIDS 15 (4), 254-259, 2004
1312004
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance
A De Luca, A Cingolani, S Di Giambenedetto, MP Trotta, F Baldini, ...
The Journal of infectious diseases 187 (12), 1934-1943, 2003
1222003
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis
A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ...
Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020
1192020
Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals
A De Luca, BC Ciancio, D Larussa, R Murri, A Cingolani, MG Rizzo, ...
Neurology 59 (3), 342-347, 2002
1102002
Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients
S Bellesi, E Metafuni, S Hohaus, E Maiolo, F Marchionni, S D’Innocenzo, ...
British journal of haematology 191 (2), 207-211, 2020
1002020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20